Key result
Quantitative and dynamic MRI methods non-invasively detect endothelial dysfunction in overt and subclinical CV disease.
Why the study?
To review recent developments in non-contrast, proton MRI methods for dynamic, non-invasive quantification of blood flow and oxygenation to detect endothelial dysfunction.
Non-contrast dynamic MRI methods offer a non-invasive means to quantify peripheral vascular function and endothelial dysfunction, serving as potential biomarkers for disease progression and therapeutic response.
Requires prospective outcome validation before clinical adoption; extends imaging research on vascular biomarkers in subclinical settings.
The endothelium regulates and mediates vascular homeostasis, allowing for dynamic changes of blood flow in response to mechanical and chemical stimuli. Endothelial dysfunction underlies many diseases and is purported to be the earliest pathologic change in the progression of atherosclerotic disease. Peripheral vascular function can be interrogated by measuring the response kinetics following induced ischemia or exercise. In the presence of endothelial dysfunction, there is a blunting and delay of the hyperemic response, which can be measured non-invasively using a variety of quantitative magnetic resonance imaging (MRI) methods. In this review, we summarize recent developments in non-contrast, proton MRI for dynamic quantification of blood flow and oxygenation. Methodologic description is provided for: blood oxygenation-level dependent (BOLD) signal that reflect combined effect of blood flow and capillary bed oxygen content; arterial spin labeling (ASL) for quantification of regional perfusion; phase contrast (PC) to quantify arterial flow waveforms and macrovascular blood flow velocity and rate; high-resolution MRI for luminal flow-mediated dilation; and dynamic MR oximetry to quantify oxygen saturation. Overall, results suggest that these dynamic and quantitative MRI methods can detect endothelial dysfunction both in the presence of overt cardiovascular disease (such as in patients with peripheral artery disease), as well as in sub-clinical settings (i.e., in chronic smokers, non-smokers exposed to e-cigarette aerosol, and as a function of age). Thus far, these tools have been relegated to the realm of research, used as biomarkers of disease progression and therapeutic response. With proper validation, MRI-measures of vascular function may ultimately be used to complement the standard clinical workup, providing additional insight into the optimal treatment strategy and evaluation of treatment efficacy.
No takes yet. Share an insight, caveat, or question.
Englund et al. (2020) conducted a review in Endothelial dysfunction and peripheral vascular disease. Quantitative and dynamic MRI methods (BOLD, ASL, PC, FMD, Oximetry) was evaluated. Quantitative and dynamic MRI methods can non-invasively detect endothelial dysfunction in both overt cardiovascular disease and sub-clinical settings.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: